Molecular Templates Cash And Short Term Investments Over Time
| MTEM Stock | USD 0.41 0.03 7.89% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Molecular Templates Performance and Molecular Templates Correlation. Molecular |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Templates. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Templates listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (3.05) | Revenue Per Share 4.544 | Quarterly Revenue Growth (0.92) | Return On Assets (0.38) |
The market value of Molecular Templates is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Templates' value that differs from its market value or its book value, called intrinsic value, which is Molecular Templates' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Templates' market value can be influenced by many factors that don't directly affect Molecular Templates' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Templates' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Templates is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Templates' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash And Short Term Investments Analysis
Compare Molecular Templates and related stocks such as Century Therapeutics, Kezar Life Sciences, and Mineralys Therapeutics, Cash And Short Term Investments Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSC | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 81.5 M | 75.8 M | 222.9 M | 315.5 M | 172.7 M | 191 M |
| KZR | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 51 M | 107.4 M | 78.2 M | 140.4 M | 208.4 M | 276.6 M | 201.4 M | 147.6 M |
| MLYS | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 10.6 M | 110.1 M | 236.6 M | 248.4 M |
| NKTX | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 37 M | 315.3 M | 240.2 M | 354.9 M | 248.2 M | 220.6 M |
| RNXT | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 1.8 M | 15.2 M | 6.4 M | 1.2 M | 1.1 M |
| TPST | 31.4 M | 31.4 M | 31.4 M | 44.4 M | 60.2 M | 126.7 M | 114.4 M | 67.2 M | 77.7 M | 63.5 M | 18.8 M | 51.8 M | 31.2 M | 39.2 M | 48.4 M |
| IKNA | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 82.1 M | 162.5 M | 232.2 M | 156.9 M | 175.5 M | 178 M |
| CTMX | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 64.4 M | 186.7 M | 181.9 M | 374.1 M | 436.1 M | 296.1 M | 316.1 M | 305.2 M | 193.7 M | 174.5 M | 253.8 M |
| ASMB | 15.9 K | 37 M | 20.5 M | 27.1 M | 29.1 M | 67.7 M | 53 M | 119.9 M | 218.1 M | 274 M | 216.4 M | 146.6 M | 91.6 M | 130.2 M | 99.4 M |
| TIL | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 8.9 M | 241.7 M | 454.1 M | 260.9 M | 150.4 M | 245.5 M |
| NUVB | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 118.9 M | 215.8 M | 765.4 M | 661 M | 611.2 M | 521.9 M |
| TARA | 83.6 M | 83.6 M | 83.6 M | 83.6 M | 83.6 M | 65.3 M | 41.3 M | 42.1 M | 21.9 M | 6.2 M | 168.6 M | 91.2 M | 84.4 M | 65.6 M | 73.7 M |
| VCNX | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 4.2 M | 19.7 M | 2.8 M | 10.6 M | 8.6 M | 6.4 M | 1.5 M | 1.5 M |
| MNPR | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 2.1 M | 9 M | 6.9 M | 13.2 M | 16.7 M | 20.3 M | 13.1 M | 7.3 M | 12.2 M |
| SRZN | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 49.2 M | 101.9 M | 75.8 M | 36 M | 64.2 M |
| ERAS | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 118.7 M | 459.2 M | 435.6 M | 312.4 M | 302.8 M |
| FBRX | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M | 31.2 M | 88.7 M | 96.1 M | 6.9 M | 58.8 M | 42 M | 41.1 M | 37.1 M | 41 M |
Molecular Templates and related stocks such as Century Therapeutics, Kezar Life Sciences, and Mineralys Therapeutics, Cash And Short Term Investments description
Short Term Investments is an account in the current assets section of Molecular Templates balance sheet. This account contains Molecular Templates investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Molecular Templates fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.My Equities
My Current Equities and Potential Positions
| Molecular Templates | MTEM |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Texas; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.41
Check out Molecular Templates Performance and Molecular Templates Correlation. To learn how to invest in Molecular Stock, please use our How to Invest in Molecular Templates guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Molecular Templates technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.